USBio Logo

G2024-53A Gemcitabine Hydrochloride (2’-Deoxy-2’,2’-difluorocytidine Hydrochloride, dFdC, dFdCyd) CAS: 122111-03-9

Specifications
References
CAS Number
122111-03-9
Grade
Highly Purified
Molecular Formula
C9H11F2N3O4•HCl
Molecular Weight
299.66
EU Commodity Code
38220090
Shipping Temp
Blue Ice
Storage Temp
-20°C
2’-Deoxy-2’,2’-difluorocytidine Hydrochloride, dFdC, dFdCyd

Gemcitabine is a nucleoside analog of deoxycytidine used as chemotherapy to treat patients with various types of cancer. After passage through the cell membrane via nucleoside transporters, gemcitabine undergoes complex intracellular conversion to gemcitabine diphosphate (dFdCDP) and triphosphate (dFdCTP). dFdCTP inhibits DNA polymerase by competing with deoxycytidine triphosphate (dCTP). dFdCDP inhibits ribonucleoside reductase and DNA synthesis by causing depletion of deoxyribonucleotide pools, and thus potentiating the effects of dFdCTP. Gemcitabine can be inactivated to 2,2'-difluorodeoxyuridine, mainly by deoxycytidine deaminase. Also, 5'-nucleotidase catalyses the conversion of nucleotides to nucleosides and inhibits nucleoside kinases.

CAS Number
122111-03-9
Molecular Weight
299.66
Molecular Formula
C9H11F2N3O4•HCl
Purity
≥99%
Appearance
White to off-white powder
Solubility
Soluble in DMSO at 12.5mg/ml with slight warming; very poorly soluble in ethanol; soluble in water at 25mg/ml with slight warming; buffers, serum, or other additives may increase or decrease the aqueous solubility.
Calculated
C: 36.07% H: 4.04% Cl: 11.83% F: 12.68% N: 14.02%
Storage and Stability
Lyophilized and reconstituted products are stable for 6 months after receipt at -20°C.
Important Note
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Toxicity and Hazards
All products should be handled by qualified personnel only, trained in laboratory procedures.
References
1. Mini, E., et al. "Cellular pharmacology of gemcitabine." Ann. Oncol. 17:v7-v12 (2006). 2. Cartwright, T., et al. "Cancer of the pancreas: are we making progress? A review of studies in the US Oncology Research Network." Cancer Control 15:308-313 (2008). 3. Huang, P., et al. "Action of 2',2'-difluorodeoxycytidine on DNA synthesis." Cancer Res. 51:6110-6117 (1991). 4. Cappella, P., et al. "Cell cycle effects of gemcitabine." Int. J. Cancer 93:401-408 (2001). 5. Sun, D., et al. "Enhancement of DNA ligase I level by gemcitabine in human cancer cells." Clin. Cancer Res. 8:1189-1195 (2002).
USBio References
No references available
Pricing
Order
Proceed to Checkout
Cart Summary
ProductSizeListYour PriceQtyExt Price
Subtotal:Subtotal:
Subtotal:Subtotal:
Total Coupon Savings:Total Coupon Savings:()
Your cart is currently empty.
- Coupon Code
Recently Viewed
  • Contact Us

    Visit our technical library or contact our support staff to answer your questions.

    Telephone:
    1-800-520-3011

    Library | Contact

    Distributors

    For customers outside of the United States, please use one of our many distributors.

    View Distributors

    Payment Methods

    We accept the following payment methods as well as pay-by-invoice.

    MasterCard Visa PayPal
    © 2023-2024 United States Biological - All Rights Reserved